British Patient Capital invests £90m London biotech company Tech British Patient Capital recently also invested £10m into biotech firm Curve Therapeutics to support its cancer drug discovery technology.
Based in an old Bermondsey biscuit factory, this London cancer drug firm just raised millions Science Founded in 2012 by a PhD student, Labgenius uses technology to create more effective and safer antibodies for cancer treatment.
US regulator accepts GSK’s application to expand treatment of cancer drug pharma The treatment, Jemperli, will now be classed as being able to help all adult patients with primary advanced or recurrent endometrial cancer. It is used alongside chemotherapy.